A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient.
作者信息
Chang Kai-Ming, Berlinrut Ilan, Wallach Frances R
机构信息
Division of Infectious Diseases, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, New York, USA.
出版信息
Transpl Infect Dis. 2021 Oct;23(5):e13710. doi: 10.1111/tid.13710. Epub 2021 Aug 16.
Abstract
摘要
相似文献
1
A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient.一名肾移植受者尽管已全程接种mRNA-1273新冠病毒疫苗（Moderna），仍感染了重症新冠病毒。
Transpl Infect Dis. 2021 Oct;23(5):e13710. doi: 10.1111/tid.13710. Epub 2021 Aug 16.
2
COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.基于mRNA的SARS-CoV-2疫苗接种后肾移植受者发生的新型冠状病毒肺炎
Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13.
3
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.肾移植受者首次接种mRNA新冠疫苗后抗SARS-CoV-2抗体反应较弱。
Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.
4
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.接受2剂mRNA-1273新型冠状病毒疫苗的肾移植受者中免疫接种率较低。
Kidney Int. 2021 Jun;99(6):1498-1500. doi: 10.1016/j.kint.2021.04.005. Epub 2021 Apr 20.
5
SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients.肾移植受者接种两剂mRNA疫苗后感染严重急性呼吸综合征冠状病毒2
Transpl Infect Dis. 2021 Aug;23(4):e13628. doi: 10.1111/tid.13628. Epub 2021 May 11.
6
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
7
Acute Cellular Rejection in A Kidney Transplant Recipient Following Vaccination with Inactivated SARS-CoV-2 Vaccine.肾移植受者接种灭活 SARS-CoV-2 疫苗后发生急性细胞性排斥反应。
Iran J Kidney Dis. 2022 Jul;16(4):269-271.
8
Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗在透析和肾移植患者中的免疫原性：一项系统评价
Tuberk Toraks. 2021 Dec;69(4):547-560. doi: 10.5578/tt.20219612.
9
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.一名肝移植受者接种基于mRNA的SARS-CoV-2疫苗后的肝损伤
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
10
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
引用本文的文献
1
COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients.接种疫苗的肾移植受者中的新冠病毒突破性感染
Vaccines (Basel). 2022 Nov 11;10(11):1911. doi: 10.3390/vaccines10111911.
2
COVID-19 despite full COVID-19 vaccination.尽管已完全接种新冠疫苗，但仍感染新冠病毒。
Transpl Infect Dis. 2021 Oct;23(5):e13712. doi: 10.1111/tid.13712. Epub 2021 Aug 21.
本文引用的文献
1
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者接种三剂mRNA新冠疫苗
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
2
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.肾移植受者和透析患者对 SARS-CoV-2 BNT162b2 疫苗的体液免疫受损。
Sci Immunol. 2021 Jun 15;6(60). doi: 10.1126/sciimmunol.abj1031.
3
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
4
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.肾移植受者中 SARS-CoV-2 BNT162b2（tozinameran）疫苗加强接种后体液和细胞免疫受损。
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI150175.
5
Occurrence of severe COVID-19 in vaccinated transplant patients.接种疫苗的移植患者中出现重症 COVID-19 情况。
Kidney Int. 2021 Aug;100(2):477-479. doi: 10.1016/j.kint.2021.05.011. Epub 2021 May 23.
6
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
7
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.接受2剂mRNA-1273新型冠状病毒疫苗的肾移植受者中免疫接种率较低。
Kidney Int. 2021 Jun;99(6):1498-1500. doi: 10.1016/j.kint.2021.04.005. Epub 2021 Apr 20.
8
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.肾移植受者在未接触过病毒的情况下，对 mRNA SARS-CoV-2 BNT162b2 疫苗的体液反应降低。
Am J Transplant. 2021 Aug;21(8):2719-2726. doi: 10.1111/ajt.16615. Epub 2021 May 7.
9
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件